{"status": "Ok", "redirect_url": "https://www.businesswire.com/news/home/20260808213545/en/SPRY-Investors-Have-Opportunity-to-Lead-ARS-Pharmaceuticals-Inc.-Securities-Fraud-Lawsuit-with-SBS-Law", "message": "News view counter 871436 successfully enlarged"}